356 related articles for article (PubMed ID: 35083862)
1. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
Peng J; Fan M; An C; Ni F; Huang W; Luo J
Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):439-456. PubMed ID: 35083862
[TBL] [Abstract][Full Text] [Related]
2. The Role of Cannabidiol in Liver Disease: A Systemic Review.
Chen S; Kim JK
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397045
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
[No Abstract] [Full Text] [Related]
4. Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease.
Silvestro S; Schepici G; Bramanti P; Mazzon E
Molecules; 2020 Nov; 25(21):. PubMed ID: 33171772
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research.
Melas PA; Scherma M; Fratta W; Cifani C; Fadda P
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668469
[TBL] [Abstract][Full Text] [Related]
6. A molecular basis for the anti-inflammatory and anti-fibrosis properties of cannabidiol.
Sunda F; Arowolo A
FASEB J; 2020 Nov; 34(11):14083-14092. PubMed ID: 32885502
[TBL] [Abstract][Full Text] [Related]
7. Cannabis for the Treatment of Epilepsy: an Update.
Gaston TE; Szaflarski JP
Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response.
Berg BB; Soares JS; Paiva IR; Rezende BM; Rachid MA; Cau SBA; Romero TRL; Pinho V; Teixeira MM; Castor MGME
J Pharmacol Exp Ther; 2021 May; 377(2):273-283. PubMed ID: 33658314
[TBL] [Abstract][Full Text] [Related]
9. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.
Chaves YC; Genaro K; Crippa JA; da Cunha JM; Zanoveli JM
Metab Brain Dis; 2021 Apr; 36(4):639-652. PubMed ID: 33464458
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol goes nuclear: The role of PPARγ.
Khosropoor S; Alavi MS; Etemad L; Roohbakhsh A
Phytomedicine; 2023 Jun; 114():154771. PubMed ID: 36965374
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
[TBL] [Abstract][Full Text] [Related]
13. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.
Campos AC; Moreira FA; Gomes FV; Del Bel EA; Guimarães FS
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3364-78. PubMed ID: 23108553
[TBL] [Abstract][Full Text] [Related]
14. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.
Campos AC; Ortega Z; Palazuelos J; Fogaça MV; Aguiar DC; Díaz-Alonso J; Ortega-Gutiérrez S; Vázquez-Villa H; Moreira FA; Guzmán M; Galve-Roperh I; Guimarães FS
Int J Neuropsychopharmacol; 2013 Jul; 16(6):1407-19. PubMed ID: 23298518
[TBL] [Abstract][Full Text] [Related]
15. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
Fasinu PS; Phillips S; ElSohly MA; Walker LA
Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection Following Concussion: The Potential Role for Cannabidiol.
Singh J; Neary JP
Can J Neurol Sci; 2020 May; 47(3):289-300. PubMed ID: 32029015
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol exerts anti-proliferative activity via a cannabinoid receptor 2-dependent mechanism in human colorectal cancer cells.
Lee HS; Tamia G; Song HJ; Amarakoon D; Wei CI; Lee SH
Int Immunopharmacol; 2022 Jul; 108():108865. PubMed ID: 35598400
[TBL] [Abstract][Full Text] [Related]
18. An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects.
Martinez Naya N; Kelly J; Corna G; Golino M; Polizio AH; Abbate A; Toldo S; Mezzaroma E
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257386
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.
Mandolini GM; Lazzaretti M; Pigoni A; Oldani L; Delvecchio G; Brambilla P
Epidemiol Psychiatr Sci; 2018 Aug; 27(4):327-335. PubMed ID: 29789034
[TBL] [Abstract][Full Text] [Related]
20. Palmitoylethanolamide: A Potential Alternative to Cannabidiol.
Clayton P; Subah S; Venkatesh R; Hill M; Bogoda N
J Diet Suppl; 2023; 20(3):505-530. PubMed ID: 34842030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]